Content by Mallinckrodt Pharmaceuticals
Mallinckrodt will acquire Questcor for approximately $5.6 Billion, creating a diversified, high-growth specialty pharmaceuticals company.
| 5 min read
Page 1 of 1 - 1 Total Items
Mallinckrodt will acquire Questcor for approximately $5.6 Billion, creating a diversified, high-growth specialty pharmaceuticals company.
CURRENT ISSUE - September 2024
Transforming lab culture through effective communication and leadership